Summary

The FDA’s new rules for TV and radio drug ads, effective Nov. 20, require clearer, distraction-free presentations of risk information, using simple language without overwhelming visuals.

While aimed at improving consumer understanding, experts warn that companies may exploit certain requirements, such as on-screen text, to dilute risk awareness.

Amid these changes, drug promotion is increasingly shifting to social media influencers, often with little regulatory oversight.

A proposed bill in Congress seeks to close this loophole by mandating risk disclosures and transparency in influencer payments tied to drug promotions.